This test is most useful if any of these apply to you.
Urine cobalt is an established tool for monitoring occupational exposure, especially in people who manufacture, grind, or sharpen hard metal. It can also help investigate exposure from a cobalt-containing joint replacement. Using it to predict heart disease, kidney disease, or lifespan in otherwise healthy people remains exploratory.
The result reflects cobalt leaving your body through your kidneys. It depends on recent exposure, the chemical form of the cobalt, kidney function, and urine concentration. A high result can help identify an exposure problem, but it cannot establish poisoning or show which organ has been affected.
Cobalt is a metallic element found naturally in food, water, and soil. Its established nutritional role in people is as part of vitamin B12. Your body needs the finished vitamin and cannot make it by combining cobalt from a supplement with other ingredients.
This test measures total elemental cobalt in a urine sample. The standard laboratory method is called ICP-MS. It detects trace amounts of cobalt across its different chemical forms, including cobalt contained in vitamin B12. The result does not separate those forms according to their toxicity.
Absorbed, soluble cobalt is cleared mainly through urine, although some remains in tissues longer. In one study of hard-metal workers, urinary cobalt fell by about half over five days after exposure stopped. That timing isn't universal: chemical form, exposure history, and continued release from an implant can change the pattern.
Iron status also affects absorption. Cobalt and iron can use some of the same transport proteins in the gut, and iron deficiency can increase cobalt uptake. In a study of four-year-old children, those with iron deficiency anemia had about twice the creatinine-adjusted urine cobalt of children without anemia. The study did not test whether iron treatment would lower cobalt.
Urine cobalt may be reported as a concentration or relative to urine creatinine. Creatinine is a waste product released by muscles. Dividing cobalt by creatinine helps account for how dilute the sample is, but muscle mass, age, and kidney function can still affect that ratio.
Cobalt-chromium components can release metal through wear and corrosion. Metal-on-metal hips are a recognized source, but corrosion can also occur at connections in other cobalt-containing implants. A particularly severe problem can develop when a fractured ceramic hip is revised using a metal bearing: remaining ceramic fragments can scrape the metal surface.
Cobaltism is illness caused by excessive cobalt exposure. Reports based mainly on blood cobalt measurements describe hearing loss, vision problems, numbness, thinking difficulties, thyroid dysfunction, and damage to the heart muscle in people with failing implants. Those reports establish that serious toxicity can occur, but their blood measurements cannot be translated into a urine level that predicts the same outcome.
A blinded study of 229 people with joint replacements found an association between spot urine cobalt and a score combining symptoms attributed to cobaltism. The symptom score was newly developed, and symptoms such as fatigue or memory trouble have many possible causes. This study supports further investigation of urine testing; it does not establish a urine result that diagnoses cobalt poisoning.
Whole-blood cobalt and chromium are the measurements used in major implant-monitoring guidance. Urine can provide additional exposure information, but it has not been established as a superior replacement for blood testing. Assessment of implant problems also depends on symptoms, examination, and imaging because metal concentrations alone do not reliably describe damage around the joint.
Several population studies have linked higher urinary cobalt to cardiovascular disease or death. These studies measured urinary cobalt directly, generally with adjustment for urine dilution and other risk factors. Their findings describe differences between groups; they do not establish that cobalt caused the outcomes.
| Who Was Studied | What Was Compared | What They Found |
|---|---|---|
| About 6,600 adults in the Multi-Ethnic Study of Atherosclerosis, followed for roughly 18 years | Highest versus lowest quarter of urine cobalt | About 24% higher rates of new cardiovascular events and 37% higher rates of death from any cause |
| About 6,400 adults from the same cohort, with coronary calcium measurements over 10 years | Highest versus lowest quarter of urine cobalt | About 47% higher modeled coronary artery calcium levels over follow-up |
| About 15,900 US adults in NHANES, followed for a median of nearly 11 years | Highest versus lowest fifth of creatinine-adjusted urine cobalt | About 67% higher rates of cardiovascular death and 26% higher rates of death from any cause |
The coronary calcium result describes differences in estimated calcium levels during follow-up. It should not be read as a 47% faster rate of calcium buildup.
Another NHANES analysis found that frail middle-aged and older adults in the highest quarter of urine cobalt had about 57% higher death rates than those in the lowest quarter. Analyses drawn from the same national survey can include overlapping participants, so they are not fully independent confirmations.
The evidence isn't uniform. A Spanish cohort found an association between a mixture of urinary metals and cardiovascular disease, without a clear association for cobalt alone. Another US analysis found no clear difference in death rates between cobalt quarters. In the larger NHANES mortality study above, associations were not significant when urine cobalt was analyzed without creatinine correction. That sensitivity matters because creatinine also reflects muscle mass and health.
Other metal exposures, kidney function, diet, and health conditions can influence these associations. Trials have not established that lowering urinary cobalt at ordinary background exposure levels prevents cardiovascular disease or extends life, and these findings do not provide a validated personal risk score.
In a Swiss cohort followed for about 12.5 years, higher baseline urine cobalt was associated with later development of a combined outcome that included mildly reduced kidney filtration or chronic kidney disease. The association remained after accounting for starting kidney function. Because that outcome included mild reductions in filtration, it should not be described entirely as diagnosed chronic kidney disease.
US survey analyses have also linked higher urine cobalt to a history of kidney stones. These studies measured exposure and stone history at the same point in time, so they cannot show that cobalt preceded or caused the stones. Kidney function itself influences cobalt handling, which further complicates interpretation.
A separate survey of about 9,100 adults found an association with overactive bladder symptoms. Cadmium contributed more strongly to the association seen for the mixture of metals. Urine cobalt has not been validated as a diagnostic test for kidney stones or overactive bladder.
Metabolic syndrome is a combination of abdominal obesity, high blood pressure, high blood sugar, high triglycerides, and low HDL cholesterol. In a prospective study of nearly 950 midlife women, those in the highest quarter of urine cobalt were about 85% more likely to develop the syndrome than those in the lowest quarter.
Insulin resistance develops when your tissues respond less well to insulin. A cross-sectional US study found about 43% higher prevalence of insulin resistance in the highest quarter of urine cobalt than in the lowest quarter. Another analysis linked urinary cobalt with blood glucose and insulin resistance, with stronger associations in men.
In about 14,800 Chinese adults, cobalt was among the metals contributing to associations between urinary metal mixtures and unfavorable blood lipid profiles. These findings do not show that lowering cobalt treats insulin resistance or abnormal cholesterol.
A meta-analysis of occupational cohorts found higher mortality from respiratory cancers among workers exposed to cobalt. Those studies evaluated workplace exposure, often alongside other substances, rather than a urine cobalt result used for cancer screening. They do not establish that a particular urine result predicts cancer in someone with ordinary environmental exposure.
Hard-metal production, grinding, blade sharpening, and some mining and metal-processing jobs can increase cobalt exposure. Urine testing is particularly useful for tracking uptake of soluble cobalt compounds. Less soluble cobalt oxides can remain in the lungs, so urine concentrations may be a poor measure of recent exposure to those forms.
Environmental exposure can also be substantial near mining and processing sites. Studies in the Katanga region of the Democratic Republic of Congo found high urinary cobalt in nearby communities. Food was a major exposure route for adults, while ingestion of contaminated dust also mattered for children.
Repeated spot samples can fluctuate substantially in occupational settings. A persistent change across comparable samples is more informative than an isolated rise, but there is no validated percentage change that establishes toxicity.
Research using complete 24-hour collections found relatively good day-to-day consistency for cobalt in healthy nonsmokers. That is a different collection approach from a spot sample, and its reproducibility cannot be assumed for individual spot results. A 24-hour total, a urine concentration, and a creatinine-adjusted ratio describe different quantities.
Evidence-backed interventions that affect your Cobalt level
Cobalt is best interpreted alongside these tests.
Cobalt is included in these pre-built panels.
See which minerals your body holds onto and which it flushes away, a research-grade look at your diet and kidney handling.
See which environmental metals your body is passing and how your essential minerals compare, from a single urine sample.
38 biomarkers